Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.

130.34
USD
+1.72
(+1.34%)
3.42EPS
22.25P/E
8.93BMarket Cap
Nov 05Next Earn

Halozyme Therapeutics, Inc. Documents

Q2 FY2026 · Quarterly report

August 6, 2026 · 75 pages

Read Halozyme Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this quarterly report
Create a free account to start reading

Full documents are included with Professional

Q2 FY2026 documents